1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cell Biology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cell Biology Market, by Product & Service
8.1.1. Reagents & Consumables
8.1.1.1. Market Revenue and Forecast
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast
8.1.3. Software
8.1.3.1. Market Revenue and Forecast
8.1.4. Services & Accessories
8.1.4.1. Market Revenue and Forecast
9.1. Cell Biology Market, by Technique/Process
9.1.1. Flow Cytometry & Microscopy
9.1.1.1. Market Revenue and Forecast
9.1.2. High-Content Screening
9.1.2.1. Market Revenue and Forecast
9.1.3. PCR / Sequencing / Other Cell-Based Techniques
9.1.3.1. Market Revenue and Forecast
9.1.4. Single-Cell Analysis
9.1.4.1. Market Revenue and Forecast
9.1.5. Other Techniques
9.1.5.1. Market Revenue and Forecast
10.1. Cell Biology Market, by Application
10.1.1. Drug Discovery & Development
10.1.1.1. Market Revenue and Forecast
10.1.2. Disease Research (Oncology, Immunology, etc.)
10.1.2.1. Market Revenue and Forecast
10.1.3. Toxicology & Safety Assessment
10.1.3.1. Market Revenue and Forecast
10.1.4. Basic & Academic Research
10.1.4.1. Market Revenue and Forecast
10.1.5. Other Applications
10.1.5.1. Market Revenue and Forecast
11.1. Cell Biology Market, by End User
11.1.1. Pharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Academic & Research Institutes
11.1.2.1. Market Revenue and Forecast
11.1.3. Hospitals & Clinical Labs
11.1.3.1. Market Revenue and Forecast
11.1.4. CROs & Other Users
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product & Service
12.1.2. Market Revenue and Forecast, by Technique/Process
12.1.3. Market Revenue and Forecast, by Application
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product & Service
12.1.5.2. Market Revenue and Forecast, by Technique/Process
12.1.5.3. Market Revenue and Forecast, by Application
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product & Service
12.1.6.2. Market Revenue and Forecast, by Technique/Process
12.1.6.3. Market Revenue and Forecast, by Application
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product & Service
12.2.2. Market Revenue and Forecast, by Technique/Process
12.2.3. Market Revenue and Forecast, by Application
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product & Service
12.2.5.2. Market Revenue and Forecast, by Technique/Process
12.2.5.3. Market Revenue and Forecast, by Application
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product & Service
12.2.6.2. Market Revenue and Forecast, by Technique/Process
12.2.6.3. Market Revenue and Forecast, by Application
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product & Service
12.2.7.2. Market Revenue and Forecast, by Technique/Process
12.2.7.3. Market Revenue and Forecast, by Application
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product & Service
12.2.8.2. Market Revenue and Forecast, by Technique/Process
12.2.8.3. Market Revenue and Forecast, by Application
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product & Service
12.3.2. Market Revenue and Forecast, by Technique/Process
12.3.3. Market Revenue and Forecast, by Application
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product & Service
12.3.5.2. Market Revenue and Forecast, by Technique/Process
12.3.5.3. Market Revenue and Forecast, by Application
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product & Service
12.3.6.2. Market Revenue and Forecast, by Technique/Process
12.3.6.3. Market Revenue and Forecast, by Application
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product & Service
12.3.7.2. Market Revenue and Forecast, by Technique/Process
12.3.7.3. Market Revenue and Forecast, by Application
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product & Service
12.3.8.2. Market Revenue and Forecast, by Technique/Process
12.3.8.3. Market Revenue and Forecast, by Application
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product & Service
12.4.2. Market Revenue and Forecast, by Technique/Process
12.4.3. Market Revenue and Forecast, by Application
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product & Service
12.4.5.2. Market Revenue and Forecast, by Technique/Process
12.4.5.3. Market Revenue and Forecast, by Application
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product & Service
12.4.6.2. Market Revenue and Forecast, by Technique/Process
12.4.6.3. Market Revenue and Forecast, by Application
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product & Service
12.4.7.2. Market Revenue and Forecast, by Technique/Process
12.4.7.3. Market Revenue and Forecast, by Application
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product & Service
12.4.8.2. Market Revenue and Forecast, by Technique/Process
12.4.8.3. Market Revenue and Forecast, by Application
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product & Service
12.5.2. Market Revenue and Forecast, by Technique/Process
12.5.3. Market Revenue and Forecast, by Application
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product & Service
12.5.5.2. Market Revenue and Forecast, by Technique/Process
12.5.5.3. Market Revenue and Forecast, by Application
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product & Service
12.5.6.2. Market Revenue and Forecast, by Technique/Process
12.5.6.3. Market Revenue and Forecast, by Application
12.5.6.4. Market Revenue and Forecast, by End User
13.1. Thermo Fisher Scientific
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Danaher Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Becton, Dickinson and Company (BD)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Merck KGaA
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Agilent Technologies
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Bio-Rad Laboratories
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Sartorius AG
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Miltenyi Biotec
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. PerkinElmer (Revvity)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. 10x Genomics
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
